Skip to content
10-Q

Quarterly Report

BIOSCIENCE NEUTRACEUTICALS, INC.

0001640334-17-002612

← back to feed
Filed
Dec 7, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2017 · Dec 6, 2017 9.5M sh
Stockholders Equity Q3 2017 · Sep 30, 2017 −$24.85K
Stockholders Equity Q3 2017 · Dec 31, 2016 −$17.37K
Current Liabilities Q3 2017 · Sep 30, 2017 $117.1K
Current Liabilities Q3 2017 · Dec 31, 2016 $17.37K
Total Liabilities Q3 2017 · Sep 30, 2017 $117.1K
Total Liabilities Q3 2017 · Dec 31, 2016 $17.37K
Current Assets Q3 2017 · Sep 30, 2017 $4.35K
Total Assets Q3 2017 · Sep 30, 2017 $92.24K
Operating Cash Flow Q3 2017 · Sep 30, 2016 −$6K
Sga Expense Q3 2017 · Sep 30, 2016 $970
Sga Expense Q3 2017 · Sep 30, 2016 $3.68K
Net Income Q3 2017 · Sep 30, 2016 −$2.77K
Net Income Q3 2017 · Sep 30, 2016 −$10.76K
Operating Income Q3 2017 · Sep 30, 2016 −$2.77K
Operating Income Q3 2017 · Sep 30, 2016 −$10.76K
Cash And Equivalents Q3 2017 · Dec 31, 2015 $1.67K